弗吉尼亚州 的 伯基特淋巴瘤 临床试验
弗吉尼亚州 有 7 项针对 伯基特淋巴瘤 的研究正在招募参与者。
弗吉尼亚州 的城市
官方研究文本(英文)
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- VCU Massey Comprehensive Cancer Center, Richmond
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT03739814A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- University of Virginia Cancer Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- 以及另外 2 项
招募中2 期
366 Days – 46 Years · 所有性别 · 更新于 2026年9月28日 · NCT06124157Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- University of Virginia Cancer Center, Charlottesville
- Children's Hospital of The King's Daughters, Norfolk
- VCU Massey Comprehensive Cancer Center, Richmond
- 以及另外 1 项
招募中2 期
365 Days · 所有性别 · 更新于 2026年9月25日 · NCT06317662Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- VCU Massey Comprehensive Cancer Center, Richmond
招募中3 期
18 至 39 岁 · 所有性别 · 更新于 2026年9月2日 · NCT03150693A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- VCU Massey Comprehensive Cancer Center, Richmond
招募中2 期
1 至 30 岁 · 所有性别 · 更新于 2026年9月1日 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- University of Virginia Cancer Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- 以及另外 3 项
招募中3 期
365 Days – 25 Years · 所有性别 · 更新于 2026年8月25日 · NCT03959085AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Research Site, Richmond
招募中1/2 期
12 岁及以上 · 所有性别 · 更新于 2026年8月19日 · NCT06137118数据来自 ClinicalTrials.gov,检索日期:2026年10月1日。每项研究自行设定入选标准,由研究团队决定谁能参与。